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It’s the signaling, stupid
 
orris White (Harvard Medical School, 
Boston, MA) had a message that went 
down well at a signaling conference. Two major 
misconceptions about diabetes, he said, can 
be corrected by putting more emphasis on 
signaling pathways.
White talked primarily about type II 
M
 
(late-onset) diabetes, which has traditionally been ascribed to 
insulin resistance in peripheral tissues, as insulin is still detected 
in the blood. “That’s ingrained in the field: you get fat; you get 
old; you make your [pancreatic] 
 
 
 
 cells work too hard,” said 
White. “But the global view of our work is that 
 
 
 
 cells don’t get 
tired if the signaling is right.”
White contests the vague notion that pancreatic 
 
 
 
 cells—
the body’s only source of insulin—get exhausted from trying 
to pump out enough insulin to meet the demands of the 
peripheral tissues. As one of his counter-examples, he cites 
the rare patients with mutant insulin receptors, who always 
have severe peripheral insulin resistance but develop diabetes 
only late in life.
This may be because a normal pancreas can meet even excessive 
requirements for insulin. In contrast, in most type II diabetics 
some of the pathways that are failing to mediate insulin signaling 
in muscle and liver might also be essential for 
 
 
 
 cell survival, 
glucose sensing, and insulin secretion. The IRS branch of the 
insulin/IGF signaling pathway seems to be the key here, and if 
you put these signaling components back into the 
 
 
 
 cells, at least 
in mice, “you can restore 
 
 
 
 cell function and diabetes goes 
away,” said White. Thus, it might be useful to design drugs or 
 
Integration goes modular
 
equence gazers can act as though 
proteins are Lego creations—an 
assemblage of domains that adds up 
to a predictable whole. And sometimes, 
said Wendell Lim (University of 
California, San Francisco, CA), that 
simplistic view might just be right. Lim 
studies signaling proteins that bind to 
two input molecules and act as integrative 
switches. In at least some cases, he has 
found that the two inputs add together 
cooperatively simply because the two 
binding domains occur next to each 
other. That simple construction can 
apparently be reproduced, and perhaps 
exploited, by biologists wanting to 
S
 
pretransplant treatments to up-regulate this pathway.
White’s signaling theory also extends to side effects. Poorly 
controlled blood sugar levels have been blamed for the life-
threatening side effects of diabetes, as tight control of blood 
sugar by frequent monitoring and administration of insulin 
results in fewer side effects. But, says White, “it’s always seemed 
to me that the other thing you are doing [in these studies] is 
normalizing insulin signaling.” When White fixes only the 
pancreatric signaling, by turning up a pancreatic transcription 
factor called Pdx1, he gets good insulin-based control of blood 
sugar. But side effects such as loss of sight and neuropathy 
remain in the periphery, presumably because the signaling 
components in these areas are still obliterated. (In the human 
subjects, by contrast, residual peripheral signaling components 
can respond to increased pancreatic signaling.)
This should not change the way that patients approach their 
therapy, says White, as good blood sugar control remains the best 
readout for good control over the signaling pathways. But the 
findings may prompt future drug company efforts to focus more on 
the peripheral signaling pathways that are doing the real damage.
 
  
 
Reference: 
 
Kushner, J.A., et al. 2002. 
 
J. Clin. Invest.
 
 109:1193–1201.
Insulin secretion (green) is lost without IRS2 (middle) but restored by Pdx1 (right).
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manipulate signaling pathways.
Lim’s protein of choice is N-WASP, 
which turns on the actin polymerizing 
activity of the Arp2/3 complex. 
N-WASP shuts itself down unless 
Cdc42 and phosphatidylinositol(4,5)-
bisphosphate (PIP
 
2
 
) are around to 
disrupt two autoinhibitory interactions. 
Lim has mapped these two interactions 
and found that they form a cooperative 
switch because binding of either single 
activator destabilizes both autoinhibitory 
interactions. The two activators therefore 
cooperate to stabilize the open or 
active state.
The apparent simplicity of N-WASP 
regulation suggests that it may be 
manipulable. Lim is replacing the 
domains that bind Cdc42 and PIP
 
2
 
 with 
other interaction domains such as PDZ 
and SH3 domains, thus creating proteins 
that respond to different signals. So far, 
he said, “it seems to be relatively easy 
to make these integrating switches.” 
The swiches may be useful as read-
outs or activators of specific signaling 
pathways.
According to Lim, a good switch 
has two primary characteristics. It is 
sensitive to inputs because its auto-
inhibitory structures involve low-affinity 
interactions that can be disrupted easily. 
And it is highly cooperative in response 
to two inputs because the two interacting 
domains are tightly coupled by a short 
and rigid linker. The linker ensures 
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Networking is the future
 
onnecting the dots is what 
dominates the life of many signaling 
researchers today. Starting with a 
known component of a pathway, the 
investigator moves up and down, one 
component at a time, by using anything 
from two-hybrid and in vitro kinase 
assays to immunoprecipitation.
But soon enough the era of making 
those links will come to a close, and 
standard interaction data, like restriction 
maps and cloning strategies before 
them, will be relegated to the talks of 
distant memory. What will replace them? 
If Tobias Meyer (Stanford University, 
Stanford, CA) is right, we will be thinking 
about much more than one protein 
binding to another. “Seventy percent 
of the papers in ten years,” he said, 
“will tackle systems questions.”
Meyer is starting out on that path by 
investigating classes of proteins, such as 
all proteins with a particular domain. 
He reported in March that the calcium-
sensing C2 domain found in many 
proteins (including protein kinase C) 
translocates to the plasma membrane 
in a discrete, step-like manner, and that 
the translocation is transient or sustained 
depending on the source of calcium. 
“You have a fundamental bistability—
C
Translocation to the membrane is 
an all or none affair in individual cells.
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that the switch is locked into either an 
all-on or all-off state.
Not all integrating switches have such 
a two-state mode of action. The cell 
cycle kinase Cdk2, for example, activates 
partially in response to either cyclin 
binding or phosphorylation, although 
WASP autoinhibition (left) is relieved by two activators (right).
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both inputs are absolutely required for 
full activation. Cdk2’s multiple activity 
states are achieved through a complex 
series of allosteric motions that are not 
easily generalizable to other proteins.
That lack of generalizability may be 
just the reason why the N-WASP style 
of regulation turns out be the more 
common variety. What is easier for 
molecular biological tinkering is also 
easier for the random tinkering that 
is evolution. Lim pointed out that 
transcriptional circuits can be rewired 
relatively easily, either in vitro or during 
evolution, by swapping promoter 
sequences. “If you want to do that for 
cytosolic signaling it’s a more daunting 
problem,” he said. “But, even though 
it is not quite the same, there is the 
same type of modularity using these 
[autoinhibitory] domains. Nature can 
use this to evolve different networks 
because of the flexibility.” 
 
 
 
Reference:  Prehoda, K.E., et al. 2000. 
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 290:801–806.
 
a switch-type behavior,” he said. “That’s 
a different type of outcome than a graded 
type of translocation.”
If similar decision points are common, 
Meyer believes that the interpretation of 
signaling networks can be simplified. 
“Instead of having to know all the 
parameters you just need to know if 
this state has been reached,” he said.
Meyer is also interested in the organi-
zation of signaling networks. “The 
pathway idea has been quite powerful 
but it is not sufficient,” he said. 
“How signaling systems evolved 
is by keeping modules 
together, with 
weaker connections 
to other modules. 
There will be some 
fragmenation of the 
structure, but it won’t 
be as simple as single 
pathways.”
The idea of linear 
pathways has worked 
well for directed and conserved pathways 
such as those in the cell cycle, he said, 
but most signaling pathways are more 
flexible and less linear, as they are used in 
different ways in different cell types.
This is where modules—proteins 
grouped into feedback systems and 
signaling complexes—come into play. 
Meyer hopes to determine the degree of 
connectedness between those modules 
by using transient expression and perhaps 
chemically activated proteins. The single 
molecule version of a module he terms a 
node, with examples including calcium, 
diacyglycerol, and MAP kinase.
Naming things modules and nodes 
doesn’t solve anything, but it might 
provide the intellectual framework for 
the next big challenge. “How can we 
simplify signaling systems to 
understand how 
decisions are 
being made”? 
asked Meyer. “All 
these [protein–
protein] interac-
tions will be in 
databases. The big 
challenge is not 
anymore to find 
what binds to what. 
The big challenge is how you put all this 
together, and understand how the 
systems are dynamically connected.” 
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